CABA - Company ID 0001759138
The table below shows Cabaletta Bio, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $225.10M | $116.64M | $60.21M | $145.61M | $131.83M | $170.61M |
| Short-term investments | $0.00 | $0.00 | $99.72M | $49.07M | - | $12.40M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $231.03M |
| $122.32M |
| $164.56M |
| $198.41M |
| $134.60M |
| $185.51M |
| Property, plant & equipment | $1.48M | $1.58M | $2.06M | $2.37M | $2.64M | $2.81M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $256.73M | $148.15M | $189.76M | $224.50M | $165.14M | $204.41M |
| Accounts payable | $5.81M | $6.38M | $8.27M | $7.19M | $6.49M | $2.18M |
| Total current liabilities | $39.91M | $41.51M | $45.73M | $41.54M | $33.99M | $22.88M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $46.13M | $44.84M | $50.29M | $46.02M | $43.59M | $30.17M |
| Retained earnings | -$611.49M | -$560.47M | -$475.04M | -$430.17M | -$385.04M | -$316.51M |
| Total equity | $210.59M | $103.31M | $139.47M | $178.48M | $121.55M | $174.24M |